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INTRODUCTION
Vitamins hA.V9 entered the lives of the people
today with almost bombastic force.

We are continually

made conscious of their nresence by advertisements, in
printed form or by radio.

These advertising media

fling their challenge -- "Have you had your vitamins
today?"

That a new vitamin should make 1 ts aJrnearance

at this stage of vitamin popularity is appropos of the
present times and their advancement.
The vitamin is K.
A few years ago, a young Scandinavian, Dam, and
his associates ( 3,, 35), described a severe hemorrhagic
disorder associated with plasma prothrombin deficiency.
The causative factor was a deficiency of certain fat
soluable substances :from an otherwise adequate diet.
Their experiments were nerformed upon chicks.

(30, 2..f)

The factor deficient from the diet of the
chicks and responsible for the hemorrhagic tendencies
of the chicks was called KOAGULATIONS V!TAMIN, in the
German and Scandinavian language.

The abbreviated form

and the name by which it is most connnonly known today,
i s Vitamin K.
Vitamin K is proving to be of value in the
clinical aspect of medicine, especially in surgery and
obstetrics.
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The aim and nurpo se of this paper is to point
out the chemistry and physiology of the vitamin, as
well as its occurance in nature and the estimation of
prothrombin.

This being shown adeauately, the next

purnose of this article is to show the part Vitamin K
plays in jaundice, by its action upon prothrombin
levels and the clotting time of the blood ulasma.
This is with reference to jaundice occurring due to
biliary fistula and to obstruction of the biliary ducts.
Jaundice has been known since antiquity. T.b.e
deleterious effect it has upon the clotting time of the
blood has been kn.own since the advent of surgery.
Vitamin K, I firmly believe, will be a powerful weapon
for the surgeon in the treatment of hemorrhage occurring because of the obstructive jaundice and biliary
fistula.

By its

us~ge,

he will be able to onerate when

the operation is vitally needed.
Finally, the question of therapeutics will be
touched unon.
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DISTRIBUTION
A search for an anti-hemorrhagic factor, which
was precipi t:lted by Dam and As sac's discovery of a

b•/JJ,JS)

hemorrhagic disorder attributable to a dietary deficiency, has been carried on intensively And unceasingly
by investigAtors.

The trial and error method was ob-

viously the only method to use in the search of the
source and distribution of the a.nti-hemorrhagic factor.
Dam and Assac ran a series of tests and found
the factor to be contained in the following in varying
amounts:

(29, 30)

(

35

Alfalfa
Grass
Chestnut
Sunflowers
Strawberries
Seeds of SUnflowers
Tuber Bulbs.

Cabbage
Cauliflower
Pine Needles
Spruce Needles
Rine Hips
Soy Bean ( 12
Feces ( s:a. )

Spinach
Nettle
Peas
Tomatoes
Hemp
Roots

These were examined and found to nossess protective
qualities for the hemorrhagic entity.
to be quite efficacious in

raisin~

Alfalfa proved

(7~

the prothrombin level

in chicks, while sunflower seeds. and roots nroved to be
a poor source for the factor.
'Ille vitamin or anti-hemorrhagic factor was found
to be in the photosynthetic portion of the plant, by (
Almquist.

This is proven by the fact that the tops of

carrots contained the vitamin, while the rest of the
carrot did not.

The leafy portion of plants proved to
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~

be a good source of Vitamin K.
stad

(3~ .3,7~

results.

Almquist, Dam and Stok-

began using an extract of alfalfa with good

A short time later, fish were found to be

rich in the vitamin, if allowed to putrify before extracting the vitamin.
Osterberg ( s 1

and Butt, et al, (A.'- ) found

the extract of fish meal to be satisfactory, in their
experiments on Vitamin K.

Almquist, Dam, Stokstad and

Glavind used extracts of alfalfa.

Next, spinach made

its apnearance, and was used by Dam, et al, in their
experiments.

Dam designated 2 mg. of sninach as a unit

of potency of the vitamin.
Vitamin K from putrified fish and the photosynthetic portion of plants, remained the principal
source, until Almquist and Stokstad found the vitamin
in feces of chicks.

(~

Greaves ( 'io ) arrived at

a similar conclusion from his exneriments with rats.
These findings focused attention upon the possibility
of a synthesis of Vitamin Kin the intestinal tract.
Greaves ( 3' ) (

'+o ) ,

by using the extract of

droppings of chicks which had been allowed to drop into
1% phenol, pointed out that synthesis of the Vitamin K
takes place in vivo.
&'nell (

'7 ),

working on the source of Vitamin

K and its possible synthesis in the intestinal tract,
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found thnt c ert71.in bacteria contain the vi tAX1in.
Escherichi.; coli, StA'l')hylococcus aureus, Bacillus
subtilis and microorganisms were found to h11ve the
vitamin, even when gro,•m 1rnon vi tRmin free media,
indicnting it to be a product of bacterial metabolism.
Almciuist and Yiose ( g' ) then identified the
form of Vitamin K (phthiocol) as the Pigment of Mycobacterium tuberculosis (human).

This pigment had been

previously synthesized by .Anderson and co-workers.
(

13

)

The possibility that Vitamin K, or a substance

possessing the anti-hemorrhagic characteristics of
Vitamin K, could be synthesized onened a new source
for obtaining the vitamin.
Fei ser, et Al, ( J (

( 37 )
)

and other investigators,

working on the structure of the vitamin, found the active portion to be due to its naphthoauinone nucleous.
Next, .Ansbacher (

15

observed that Vitamin Kand other

phytyl (natural) derivatives of methyl naphthoquinone are
not as active and not as readily utilized by the animal
body as 2-methyl-1-4, nanhthoouinone, which is not from
nature, but synthesized in the 111boratory.

This man-

made product proves to be more potent, more rapidly
absorbed and more easily utilized by the body, than the
Vitamin K obtained from nature.

- 6 -

In summarizing, we see the principal source
of the anti-hemorrhagic factor is the photosynthetic
portion of plants, putrified fish, hog liver oil,
bacterial and synthetic source.
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CHJ!MISTRY
In 1935, Hendrik Dam ( .3 o

) ,

while working

on the nature and distribution of the anti-hemorrhagic
factor, discovered thr-i.t the factor is a fat soluable
vitamin, occurring in hog liver, hemp seed and vegetables.

The anti-hemorrhagic factor was localized in

the fat soluable, unsaponifiable, non-sterol fraction.
It proved to be stable to moderate heating.

7

) ( 71

In the early stages of the work on the antihemorrhagic vitamin, the extracted material was
saponified in alcoholic potassium hydroxide to remove
the fat and chlorophyll.

Alfalfa was the source used.

The extraction was performed by using hexane.

This

hydrocarbon solvent extracts less extraneous material
than other tynes of solvents.

It soon became apparent,

however, that the non-saponified :rraction had up to
50%

less notency than the crude extract.

FUrther

treatment of a non-saponifiable preparation with alkali resulted in the loss of more than
activity.

?5%

of its

This showed th::it the vitamin was alkali la-

bile.
It rEmained for Almquist (

~

) to add the next

step to the knowledge of the new vitamin.

He ( 7

) had

previously obtained concentrates of high potency by adding activated magnesium oxide (in place of the alkalis)
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to the hexane extract, causing no loss of potency of
the extrAct.

Next, activated carbon was added to

remove in part the orange and red pigment remaining,
the carotene and xanthophyll.

Following this, the

step of concentrating the hexane solution and chilling out the fats and sterols.

The hexane solution

was evaporated to dryness under a vacuum.

The solid

residue was taken up with methyl alcohol at fifty
degrees.

This was chilled for twenty-four hours at

a negative 1.1 degrees.

The solution was then c entri-

fuged, the solid reddish material containing sterols
being discarded.

The solution was again chilled, and

the nrocess reneated.

Finally, upon the addition of

10 c.c. of water to the mixture, there ensued a separation of about 2 c.c. of a reddish oil.

This was dried

under a vacuum and dissolved in hexane, then allowed
to evanorate under a vacuum at room temnerature.
These reddish oils contained the Vitamin K•
.Almquist ( &1

) , by using these concentrates

in a specially constructed retort which had a heating
element constructed about the closed end of the retort, was able for the first time to obtain the antihemorrhagic factor in a crystalline form.

It ( (, )

was determined, at this tjme, bv Almquist, that the
final attainment of a colorless concentrate shows the
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vitamin to be colorless.

It was during this experi-

ment that he confirmed his previous finding ( / o ) ,
namely, that the

~nti-hemorrhagic

factor, Vitamin K,

contAined the Benzene Ring or nucleus.
Binkley, et al, (

11 )

by

the use of decolso,

permutit and dorco as absorbents, hr:ive isolated Vitamin K in a nractically pure state.

Then, crystalliza-

tion, distillr:ition and recrystallization gave the nure
vitamin.

Next, they converted the vitamin into the

diacetate of dihydro Vitamin K with a notency of 500
units per mg.

Then, by means of the Grignard reaction,

the diacetate has been converted back to Vitamin K,
with 100% enhancement of potency, 1000 units per mg.
This is an improvement over Almquist's method, in that
he lost 50% of the vitamin and the concentration was
unpredictable.
Vitamin K2 was converted to the diacetate of
dihydro Vitamin K2 by the same method used for Vitamin
Kl.

Binkley, et al, ( 19 ) offered this as proof that

Vitamins Kl and K2 have been isolated.

The names,

Vitamin lG. and Vitamin K2, were given by Binkley, et
al (

.2t:f.: ) •

In their article on "'llie Isolation of

Vitamin K0

11

as :follows:

"Since two dif'ferent -pure substances

) ,

they exnlained their terminology

possessing Vitamin K activity were isolated, the
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compound from alfalfa, which has the smaller molecular weight, was called Vitamin Kf. and the compound
from nutrified fish meal having the larger molecular
weight, Vitamin K2."
During the Past year, observations made by
Almquist and IG.o se ( 5

)

(

t

) (

11

)

(

..s ) ( -

),

have revealed that the nanhthoquinone structure constitutes the essential structure of Vitamin K.

A

variety of naphthoquinones may cure the Vitamin K
deficient chicks and other species, some in as low
amounts as one mg.
Accord1.ng to Binkley, et al, (

.2.o )

Vitamin Kl

is, as follows:
1.

Obtained from alfalfa;

2.

Vitamin K -- light yellow oil at room
temperature;

3.

Changes u~on cooling into a crystalline
condition;

4.

Potency of about 1000 units per mg.

5.

Molecular Weight estim,,.tes vary from
443 to 568;

6.

(

~/

Absorption maxima 243,248,261,2?0 and

323 Mu.;
?•

Structural formula was found to be
2-Methyl, 3-Phytyl ...1, 4-N aph thoquinon e.
( Ir)

8.

See following nage for structural formula.
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0
I/

Vitamin K2:
1.

Obtained from fish meal;

2.

Molecular weight estimates vary from
628 to 654; ( I ~ )

3.

Potency approximately 600 units per mg.
( 'l.I

4.

)

Absorption maxima 244, 249, 264, 270,
332; ( 37

)

The chemical structure and formula of Vitamin
K2 was recently revealed by Binkley, et al, (

~')...)

at

the 34th Annual Meeting of the .American Society of
Biological Chemists, held March 13-16, 1940.
"A model experiment in which the diacetate of
dihydro Vitamin Kl gave an excellent yield of 1, 4diacetoxy-2-methylnaptholene-3-acetaldhyde, which was
further characterized as the semi-carbozone.

Ozoniza-

tion of the diacetate of dihydro vitamin K2 under the
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same condition gave 1, 4-diacetoxy-2-methylnaptholene
-3 ac etaldehyde.

Annlysis and mixed melting point

showed this aldehyde as well as its semicarbozone to
be identical with the sr-ime compound obtained from
Vitamin K.

The isolntion of this aldehyde shows conth~t

clusi vely

thoquinone.

Yi tAmin K2 is a 2-met'tyl-l, -'l:-naph-

From the ozonization reaction, levulin-

aldehyde was isolated ns the bis-2, 4-dinitrophenylhydrozone in 811G yield, based on the assumption that
one mole of the vitRmin would yield five moles of
1 evulin-aldehyde~'
'

1

Acetone was also isol::ited from the ozoniza-

tion mixture in 56% yield, assuming that one mole of
acetone originates from one mole of Vitamin K2.

The

acetone was characterized as the 2, 4-dinitrophenylhydrozone and by idiometric titration."

c 41 H 56 C2 is the empirical formula proposed
as correct for Vitamin K2.

,,

0

- 13 -

Ansbacher (
other phytyl

1~ )

stated that Vitamin IQ and

deriv~tives

are not as active, nor as

readily absorbed by the animal system as 2-methyl-1
-4-naphthoquinone, which is actually the nucleus of
Vitamin IU and Vitamin K2.
E:nmet, et al, ( 3 lo ) have found thnt of the
various

com~ounds

prepared in their laboratory 4-

amino-2-methyl-1-na.phthol and 4-amino-3-methyl-1naphthol are the most potent and easiest to utilize.
These preparations are taken up by the body more
readily than the Vitamin Kl and Vitamin K2.

These

prenRrr-itions likeVlri se will go j_nto solution, thus
rendering them

~wail able

and sui t11ble for injection.

'Ihese laboratory prenarations owe their solubility
in solutions and their greater ease of utiliza.tion
in the htunan body to the difference in structure from
that of Vitamin IQ and Vitamin K2.

The difference

lies in the fact that these nreparations have the 1
and 4 positions, hydroxy group and the amino group.
The fact that these laboratory prenared compounds ·will go into solution, are three times as
active as Vitamin Kl, and are easily utilized by the
body, promises to add a nevi concept to the antihemorrhagic therapy.

(

3~

)
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New advancement will in all probability take
nlace through these nffiv prenarations.

The amino

group will react with HCl to form the chloride of the
sub stance.

In the body, these preparations will be

oxidized.

0

Ori

II

·CHJ

-~ Hj

Q,

>
••

I

t1t-l~·f1CL

()

We see, therefore, both Vitamin Kl and Vitamin
K2 have the same nucleus, namely, a 2-methyl-1,-4naphthoquinone.
The difference lies in their side chains.

Vita-

min Ki. possesses the following side chain:
CH :2- CH : C - ( CH.a Lr

CH

~

- CH (CH )a
CH~

J.

-7

-

CH ( CH )

CH

.a.

J

Vitamin K:2 possesses this side chain:
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.,.,- CH_,

CH

- - CH

~

PHYSIOLOGY
The chief functions of Vitamin Kin the body,
so far as is known, appears to lie in its utilization
by the liver for the maintenance of a normal concentration of prothrombin in the blood plasma.

Until the

enigma of prothrombin, namely, its chemistry, has been
solved, the mechanism by which the vi tArnin affects nrothrombin will probably remain obscure.
llBecause of their bearing upon the development
of clinical states of Vitamin K deficiency, attention
has been focused unon factors which influence the absorntion of Vitamin K.

Perhaps the most imnortant of

these are the bile SRl tsr'.

(

.i.1

Proof for this fact may be seen in the absence
of an adequate amount of bile salts from the intestines.
This can be observed in obstructive jaundice and bile
fistula.

A

resultant fall in prothrombin of the Pl As-

ma occurs, while on the other hand, unon administration
of bile salts, a resultant rise is seen in the plasma
prothrombin.
Rhodes (

5~ )

states that sodium deoxycholAte

is probably the most effective bile salt per unit
weight.

He fUrther states

th~t

the hemorrhagic ten-

d ency in jaundice is due to a deficiency in plasma
prothrombin, which in turn, is due to a K avitaminosis,
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ano tbis results from a l:qck or absence of bile S!'llts,
in the intestinal tract.
Greaves (

to )

came to the conclusion that

bile in the intestine is necessary for absorntion.

'ro

nrove his contention, he ligated the biliary ducts of
rats, and maintained them on a stock diet.

The rats

became icteric, with a loss in prothrombin a.nd also, a
loss in the coagulabili ty of the blood.

VJhen the flow

of bile was again established into the intestinal
tract, the prothrombin level increased, as did the
coagulability of the blood to normal, within a short
neriod of time.
Greaves kent his experimental rats on a low
fat diet for a period of 30 to 35 days.

Then a con-

dition was noted, where the animals when inflicted
with small cuts, underwent prolonged bleeding.
prothrombin levels were low.

'l'he

Administration of 2 -

3 c. c. of beef bile brought the nrothrombin level up
markedly.

Here the loi.q stock diet contained enough

alfalfa to supnly the normal demnnd for Vitamin K,
yet the bile fistula rats developed loss of blood
coagulability upon maintenance on this diet.

Only

when bile s!'ll ts were added, or massive amounts of
Vitamin K, did the coagulr:ition time of the blood return to normal.

These exneriments point towards a
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ve-ry significant possibility, that bile salts act as
a carrying agent for Vitamin K across the intestinal
tract.
Brinkhous, et al, ( >3 ) have studied the
effect of feeding bile or bile salts supnlemented
with a fat soluable extract of alfalfa on the prothrombin level, in a number of cases of obstructive
jaundice with hypoprothrombinemia.

'.Ihey f01md that

the feeding of bile alone gave a rise 1n prothrombin
level, but the rise was very gradual.

In contrast,

they obtained a ranid rise in the prothrombin level
upon administering the bile and alfalfa extracts.
In two of their cases, the prothrombin level rose
ranidly during periods of increasing jaundice, indicating jaundice ner-se is not the essential factor.
Hawkins A.nd Brinkhous ( 'f 3 ) fed bile to
bile fistula dogs, and kept the plasma prothromb:in
levels within the limits of normal.

The dogs were

kept on a diet which contained Vitamin Kin small
quani ti es.
Sn ell

( t, 1 ) , another investi @:A.tor, is in

accord with the above findings.
It remained for Grea.ves ( .s 'I

)

to demonstrate

thRt bile is necessary for the absorption of Vitamin
K by the rat, and that in animals subsisting on a diet
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deficient in Vitamin K, bile has no effect on the
hemorrhagic tendencies, whereas, Vitamin K and bile
salts are effective immediately.
These investigators, in their exneriments
and demonstrAtions in the rAt, dog and in man, have
shown fairly conclusively that bile acids act as
carrying agents for the nassage of the fat soluable,
Vitamin K, across the intestinal mucosae.
The exact site of Absorption of Vitamin K
through the intestine has not been definitely proven.
However, work performed by Dixon and Clark of Mayo's
( 2 5 ) indicates that the jejunum is the site where
the absorption is at its maximum, while it does not
seem to be absorbed by the stomach or colon.

In sub-

stantiation of jejunum as the site of absorption, we
might quote Snell's statement to the effect that in
cases of Sprue and Hegional Ileitis, "deficiency of
prothrombin because of an insufficient intestinal absorntion of Vitamin K, hAs been noted

I!.

(

(,7 )

The answer to the auestion of prothromhin
~orrnRtion

and the role played by Vitamin K in this

process is being sought by a number or investigetors,
rit

nresent.

"There is considerable evidence that the

liver is the chief, if not the only site of formation
of prothrombin, and that an a&:rna.te amount of normally
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functioning liver tisfme is essential for the proper
utilization of Vitamin K in this :orocess."

( .l 1 )

Warner ( 7 J. } offers support to the above
statement with his ·work on albino rats.

He found

that "extirpation of a large portion of the liver in
rats resulted in a marked decrease in the nlasma prothrombin".

The nlasma prothrombin 1 evel gradually

returns to normal during the neriod required for
restorAtion of the liver to its normal weight.
Roderick ( {p/ ) renorted in 1929, thAt cattle
that

~vere

fed toxic sweet clover suffered from marked

hynoprothrombinemia and hemorrhage.

Autopsy revealed

liver necrosis.
Recently, Smith, Warner and Brinkhous {

(p S' }

renorted a bleeding tendency in dogs that were inflicted with chloroform intoxication.

Plasma pro-

thrombin decreased in proportion to the liver injury.
3ni th, Hoff.man (

G. r, )

and other investigators

on this subject are agreed that the evidence compiled
to date points strongly towards the liver as the site
of formation of

~rothrombin.

At present, little is

known of the chemistry of prothrombin.

Undoubtedly,

rt=ipid strides in the investigBtion of nrothrombin and
its source will take nlace, as soon as more is known
of prothrombin ner-se.
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Recent investigations of Greaves indicate that
Vitamin K is not stored in apnreciable qurmti ties in
the liver of rats.

( fo )

This necessitates the find-

ing of a possible endogenous source of Vitamin K, in
order to explain how, in the absence of Vitamin K from
the diet, experimental animals maintain prothrombin
levels within normal limits for long periods of time.
Greaves ( )'f ) investigated the nossible manufacture or synthesis of Vitamin Kin the intestinal
tract.

He found the anti-hemorrhagic factor in the

dronnings of chicks, which he collected and extracted
and gave to chicks suffering from low prothrombin
levels and hemorrhagic tendencies.
droppings was added to a diet of

K

The extract of
avitaminosis.

These

findings annarently substantiated the assumption that
Vitamin

K

was synthesized in the intestinal tract by

bacterial action.
Almquist and

~'tokstad

( 3

confirmed the a-

bove findings and concluded that the vitamin was evidently synthesized by bacterial action, either after
the droppings were voided, or within the lower portion
of the digestive tract where absorption could not
readily take place, or both.

In order to ascertain

where the synthesis took place, they performed the
following experiment.
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The modified basal diet of lilmquist ( .3
w11.s given to chicks up until they were four weeks
'11.h.e basnl diet is as follows:

Of age.
1.
2.
3.

4.
5.

Ether extracted fish meal
l:!.'ther extracted dried Br evver' s
yeast
NaCl plus small amounts of cupric
and Ferrous Sulfate
Cod Liver Oil
Ground polished rice

l?.5
?.5
1.0
1.0
?3.0

This diet cont11.ins ingredients anproximately,
as follows:
Protein
Ether Extract ( 3
Ash
Phosphorous
Calcium

18.27'0
2. 67'~
4.9%
0.5%

)

0 • 91/o

The above diet, when suunlemented with the
anti-hemorrhagic factor, allows chicks to maintain
good health and normal growth.

The diet not so sup-

plernented causes severe hemorrhages and eventual
death.
Droppings from these four week old chicks
were collected after the feces had dropped into trays
containing

1%

Phenol in aqueous solution.

The ration-

ale of the Phenol was to inhibit further bacterial
action.
vals.

'11.h.e droppings were collected At 24 hour interThe droppings were then dried by severAl changes

of ether.
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The alcohol and ether extracts were mixed and
diluted with a large amount of water.

The ether solu-

tion was washed several times with sodium hydroxide
solution and WAter.

.As a source of anti-hemorrhagic

vitamin, the ether solution was found to be adequate
at an equivalent level of 870, marginRl at 470 and inadequate at

2)a.

The notency of the solution was

somewhat less than that of the extract obtained from
droupings falling on the ground.
Later, Almquist, et al, ( 9

showed that

bacteria, in the following manner, are essential to
the synthesis of Vitamin K:
1.

Fish meal sterilized gAve no nrotection
to chicks;

2.

Ii:tsh meal, nlus bacteria, nrotected chicks
against hemorrhage.

Recent observations of Almquist, Pentler, and Meechi,

( ? ) and Snell ( tJ,7 ) indicate th11t an anti-hemorrhagic factor possessing similar qualities as found in
Vitamin K, is present in certain

s~ecies

of bacteria,

namely, Escherichia coli, Staphylococcus aureaus,
Bacillus subtilis and many microorganisms.
Recently, .Ansbacher and Fernholz demonstrated
the Vitamin K r-i.cti vi ty of phthiocol, which contAil'l~,'(
the naphthoquinone nucleus.

This nucleus is found in

Vitamin Kl. and Vitamin K2 and the pigment of :Mycobacterium tuberculosis.( 13 ;
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These observations indicate Vitamin K, or
Vitamin K like substances, are nresent in certain
species of bacteria and are the product of bacterial
metabolism.
While much has been accomplished, there still
remains a considerable amount of investigation of the
role played by bacteria in the nroduction of Vitamin
K, or Vitamin K like substances, in the intestinal
tract.

Whether such a role will nrove important or

not, remains to be disclosed in the future.
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CLINICAL ESTIM 1\TI ON

The nresence of VitAmin K deficiency is detected clinically by the demonstration of a decrease
in plasma prothrombin.
Howell ( tt ) used the clotting time of recalcified plasma as
present.

A

meRsure of the prothrombin

However, (luick ( .53 ) pointed out that in

reality, the so-called ttHowell' s Prothrombin Timer'
method does not aPPArently determine prothrombin time,
as the thromboplastin from the Platlets is even more
imnortant in influencing the clotting time than is
nrothrombin.
Warn er, et al,

("10

)

originated

A

met-. hod for

the aur:i.nti tritive estim::ition of PlA.smn nrothromhin which,
al though very exact and nrec ise, is regarded as too

complex for routine use in the clinicAl laborr-itory.
7'.1uir -::1ethod for the quanti tA.ti ve estimation of plasma

prothrombin (

"lo

following mr-i.nner.

differs from '{,uick' s method in the
',J,uick, et al, use the total clotting

time, which is made up of the prothrombin conversion
time and the time required for the thrombin to react
with the fibrinogen.

Warner, et al, separated the two

phases by converting the prothrombin to thrombin, then,
by merins of a serial dilution technique, the thrombin
that is formed may be titrnted.

-

25 -

:!:Jr eviously, the prothrombin wrrn

1:)

arti rilly

altered in nreliminary nurificRtion, or wns converted
incomnletely into thrombin.

Often the thrombin form-

ed wns Allowed to disintegr11te nartially before
ti trntion, with resul trmt wer-ik thromhin solutions
which renresented a small and vnrinble fraction of
the total plasma prothrombin.
In Warner's method, care hr-is been taken to
effect complete rind rBnid conversion of prothrombin
to thrombin.

.Also, by making the serial dilutions

before activating the prothrombin instead of after the
thrombin has been formed, the possibility of thrombin
disintegration has been mitigated.

This so dilutes the

tmti-thrombin thnt it does not interfere ,Ni th the
ti trnti on.

"The nroblem of fixed stt?TidArds has been

solved by using a standard clotting interval as a
fixed noint.

The degree to which the unknO\m solution

is diluted in reaching this point, gives a measure of
the amount of thrombin present.

We are then able to

exnress this amount in uni ts of dilution."

( ?o

)

"The nrothrombin of pla.smn can be converted comnletely
into thrombin by adding an optim11l amount of calcium
and an excess of thrombonlastin.

For convenience in

this work, we hnve defined thrombin of unitary concentration as being of just sufficient strength so that in
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the presence of fibrinogen (0.08 - 0.10 nercent), it
will form a clot in fifteen seconds.

rlhe pH of the

reagents is adjusted to 7.4 and the titration is
carried out at a room temnerature of 28 degrees

c.

Prothrombin of unitary concentration is defined as
being of sufficient strength, so th!:!t when completely
converted, it will fom. an equal volume of uni tAry
thrombin."

'70

)

The reagents used, are as follows:
1.
2.
3.
4.
5.
6.

Oxalated saline;
1~ssue extract (thrombonlastin);
Oxalated plasma;
F'ibrinogen;
Calcium;
Henarin.
For the prenarntion of the above mentioned re-

agents, the reader is referred to the original article
of Warner (

7o

) •

The nlasma is defibrinated before titration is
carried out.

This is accomnolished by using thrombin

for the defihrination.

The thrombin is prepared by

mixing three drons of tissue extrAct, cnlcium .'3nd nlAsma,
with six drons of sr-iline.

The thrombin is expressed

from this mixture and used At once.

"Thirty drops of

the plasma were now defibrinAted by adding three drops

of thrombin.

A clot is formed in eighteen seconds.

After allowing fifteen minutes to insure complete clotting and destruction of excess thrombin, the fibrin w11s
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rolled out.

The exnressed fluid, containing the nro-

thrombin Vias diluted 1-20, 1-30, and 1-40, with
oxalnted sriline.

tested for thrombin, these

',~hen

solutions did not clot fibrinogen.

To test them for

prothrombin, we mixed three T)arts of eCTch with three
of saline, three of calcium nnd three of tissue extract.

After sui t.qble Deriods of incubation, we

Added three drons of fibrinogen to twelve drops of
eRch incubated mixture.

The clotting

ured with a ston watch.

From data already given,

WtlS

then meas-

the total pl11sma dilution can be calculated. 11

(

?o

"The thrombin concentration tynically rises to a
plateau, which is maintained for a safe interval of
time. "

( ?()
In their example, the nlateau of thrombin

showed a fifteen second clotting time w1 th the plasma
diluted 1-223.

Therefore, the nrothrombin unit concen-

tration v1ould be 223, since one unit of thrombin,
according to Warner's definition, is eou11l to one
unit of nrothrombin.
The Above findings were of dogs.

In estimating

the nrothrombin content of human nlasma, lower concentrations will be f'ound.
later.

Two modif'ications were made,

The PlAsma is defibrinated by their thrombin

preparation, which is added to the plasma.
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The thrombin

is so diluted th,,t a clot forms in 15-18 seconds.
second change is the usAge of acacia.

The result is thnt

higher 'brothrombin uni tage" is possible.
(:~).lick,

et ril, (

!13

} by I'WA.ns

rI'he

i)f

( 1/

}

a new test,

vrnre able to determine prothrombin levels in the plasma.
A complete account of the procedure can be found in the

original article (

53

}•

9 c. c. of blood were withdrawn

rapidly and mixed with 1 c.c. of M/10 sodium oxalate, and
then cintrifuged at low speeds for 5 minutes.

bmall

amounts of the plasma, 0.1 c.c., were transferred to a
dry clean test tube, 13xl00 m.m., and mixed with equal
amounts, 0.1 c.c., of thromboplastin solution.

Next,

O.l c.c. of M/40 calcium chloride was added and the mixture quickly shaken 1'!nd nlaced in w11.ter, both at 37
degrees

c.

"The exA.ct time required for the formation

of a solid clot is recorded. n

(

.s 3

)

If active thromboplastin is used, normal human
plasma should clot in 22 to 25 seconds.

Assuming that

the clotting time is dependant on the prothrombin concentration, any dilution of nlasma should produce a
delay in the coagulation.
~.:,uick

'I'his actually occurs, as

has proven.
Increased amounts of thromboplastin are added

to the plasma, which has been diluted so that the
prothrombin has been reduced to 1/5 of normal.
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The

clotting time is increased to 65 seconds.

In order

to mitigate the possibility that the prolonged clotting time is due to dilution of some other consti tuent in the ulasma, dilutions were made with normal
saline and plasma thAt had been
hydroxide.

tre~ted

with aluminum

The aluminum hydroxide removes or inacti-

vates prothrombin with no apnarent change resulting
to the other constituents of the plasma.

The results

were the same, indicating that the decrease in plasma
prothrombin is responsible for the plasma clotting
time.

In order to have standard results and carry out

the prothrombin test successf'ully, it is necessary to
have an active and stable thromboplastin.
Rabbit's brain proved most efficacious as the
source, since it is both active and stable.
paration is as follows:

The pre-

Remove superficial blood

vessles from the brain of rabbit, \'lash and grind to a
paste and spread on a glass in thin layers; dry at 37
degrees

c.;

remove material and place in stoppered cai-

tainer; then add 0.2 gm. of this material to 0.3 c.c.
of 0.85% sodium chloride and mix, then incubate for
15 minutes.

This emulsion, when added to plasm.a

(human), causes clotting in 22 to 25 seconds.
emulsion is stable.
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This

~uick

brings out the fact that F:tbrinogen,

which is in the plasma normally at concentrations of
0.3 to

o.?5~,

clotting.

plays a passive pArt in the role of

(SJ)

However, total absence of Fibrino-

gen has been renorted by Rabe and Saloman ( 58' ) , and
Opitz and Frei (So

), with ensuing fatal hemorrhage.

Regarding calcium, Quick says that, contrary
to common belief, it seem.s more likely that only
organically combined calcium is directly essential
for the form.Ation of thrombin, and not the ionized
calcium of the blood.
berlain 's (

h?i>

1

>,uick uses Scott's and Cham-

findings in this article.

They demon-

strated that the quantitative removal of ionized calcium from the blood with oxalate, will not prevent
clotting.
~uick

( s+ ) later revised the quantitative

determination of prothrombin, as follows:

1,

4.5 c.c. Blood plus 0.5 c.c. Sodium
Oxalate solution, centrifuged;

2.

0.1 c.c. plasma nlus O.l c.c. thromboplastin•

3.

O.l c.c. Calcium Chloride then added
quickly, after which, observe the length
of time it takes to clot.

Normally, this will be 12 to 13 seconds.

With a de-

crease in prothrombin, the clotting time is delayed.
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By means of the following chart, the nrothrombin content can be determined:
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l
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A simple bed side test for the clotting time
has been perfected by Ziffren, Owen, Hoffman and
3nith (

75

It is a simnlification of 'filick''s test,

)•

and like his so-called "prothrombin test", measures
not only prothrombin, but the slllllID.ation of several
variables, thus giving a practical test for the tendency to bleed.
The test is run as follows:
1.

O.l c.c. of thrombonlastin is nlaced in
a 3 c.c. tube;

2.

1.0 c.c. of freshly drawn blood is run
into the tube;

3.

'J1he tube is inverted once, and then gently tilted every few seconds;

4.

The clotting time is observed;

5.

Repeat test on a normal individual, then
the unlmown is exnressed in percentage
of the normal, as expressed by the follm•.ring formula:
Clotting Ac ti vi ty _ Clotting time of normal
(In ~o of Normal) - Clott:'_nr~ time of unknoV'rn x l0n
The thrombonlastin is prepared as follows:

"Ex:tract 10 gm. gound brain or lung (ox or rabbit\ 2
hours with 10 c.c. saline; strain and preserve in refrigerator."

"Variable potency does not affect the

clotting time ratio of unlmown to control.

If normal

values exceed 60 seconds, the thromboplastin is rejected;
if less than 25 seconds, one should dilute the thromboplastin with saline."

( 75
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The originators of this new test comnared this
test with the quantitative nrothrombin test of Warner.
Ten cases were used for the comparison.
Sex

Diagnosis

Pernicious Anemia
.A.plastic .Anemia
Cholecystitis
Obstr. Jaundice
It

"
Biliary

"n

Fistula
Obstr. Jaundice
1
"Toxic Hepoti tis"
Obstr. Jaundice

(%

(~5

New Test
Quant. Prothromof Normal) bin Test {% of
Normal)

F

100
93
90
76
62
60
50
41
31
22

M

F
M
M
M

F
M

M
M

98
83

92
80
73
60
49
46
23
13

For all intents and nurposes, the above test
or Quick's test, prove satisfactory for the clinical
use.

Many clinicians and techniciA.ns modify the Quick

test by using less blood.

The r3tio of the remaining

constituents is not changed.
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BILIARY FISTULA AND
OBS'-~RucrrIVE

JAUNDICE.

"The earliest renorted case of fatal bleeding
in a patient having jaundice was made by Wedelius, in
1683."

( 7 r' )

(

,_5 )

Since the advent of aseptic

surgery, the tendency to bleed in natients hnving
jaundice has been helplessly noted.

This condition

has caused grave concern to surgeons, innumerable
times.

The syndrome, jaundice, then bleeding, and

then death, occurred so often it became almost an.edict
of surgical hierarchy, that to onerate on such cases
meant death for the patient.
lt"'rom the time Wedelius first renorted the
syndrome in the literature, up until c:,uick made his
observations, little effective treatment was forthcoming to the afflicted.

This was not because effort

h.qd not been ex11ended, but quite the contrary, for investigators have literally turned the gall bladder
inside out, seeking the answer.
Greaves and Schmidt ( 9t ) , in 1933, demonstrated that little or no irradiated ergosteriol is absorbed
from the bile fistula rat ( -

)•

However, when desoxy-

cholic acid was administered by mouth, it served as a
carrier of irradiated ergosterol across the intestinal
wall of the bile fistula rat.
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This work proved that

bile salts are needed for the absorption of fat soluable vitAmins, such
Their work

VitAmin D.

AS

the outgrowth of }Javlov, Looser,

WAS

V/isner, Whipule, Seidal ·And other early investigators,
who pointed out the fact that exclusion of bile from
man snd certain other animals leads to Osteonorosis.
Seifert ( (,'I ) suggested that in the absence of bile,
Vitamin D is not absorbed, which consequently leads to
a negative calcium and phos:ohorous balance.
1

I1his work played an important part in discover-

ing the mechanism of Vitamin A and Vitamin D.

Years

la.ter, it again was to be used in expl11.ining the mechanism of Another vitamin.

This Vitamin is K.

Dam and his associ0tes, while worldng on experiments with chicks, :found thr-it if certain factors are
missing from the diet, a hemorrhagic condition ensues.
They lAter found certain foods would alleviate this
condition.

1bus, Vitamin K was born into the world, and

from that time on, has been subjected· to the scientific
scrutiny of investigators anxious to clear up the enigma
of hemorrhage in jaundiced patients.
Vitamin K was found in alfalfa and other leafy
substances, the photosynthetic nortion of plants.

Next,

it wris found in putrified fish, in eggs, in hog liver
oil, in hemp seed and many other sources.

- 36 -

studying these factors.

They, therefore, developed

a method for nrothrombin detection and for the prenaration of a stAble and active thrombonlastin.

"In

studying the nl!'.l.smn from various types of ,inundiced
natients by this new method for determining prothrombin, it

WAS

diminished.

found that this component was greatly
Instead of obtaining a normal clotting

time of 22 to 25 seconds, a delay, which in one case
was as long as 90 seconds, was obtained."

( S3

)

"'These findings, therefore, suggest that the hemorrhagic tendency in Jaundice is brought by a diminuation
of prothrombin."

(

53

)

This suggestion by Q:uick nroved to be a tremendous boost for the search of the cause of hemorrhage in Ji:wndice.
The first direct evidence reported in support
of the new theory was supplied by Greaves and Schmidt

( 't-.:L ) •

They showed that when rats w:i.th biliary fistu-

las were maintained on a low fat diet for periods of
30 to 50 days, a small scratch would result in prolonged
bleeding, v.rhich in some cases led to the death of the
animal.
Quick' s method for deterrninj_ng the prothrombin
found that the loss of nrothrombin closely narall eled
the hemorrhagic tendency.

It was fUrther noted that the
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prothrombin content of these animals would have to be
reduced to 20'/o to 30'/o of normal, before the coagulation time of the blood was markedly reduced.

A

marked

rise in the prothrombin content of the blood was noted
to take nlace within 2 to 4 days after the administration of 2 to 3 c. c. of beef bile.

Vii th the increAse in

prothrombin content, a decrease in clotting time was
noted.
Vita.min K extracts, when fed to the bile fistula
rats, were effective in decreasing the clotting time
and increasing the prothrombin content.
Next, the rats were made icteric by ligation of
the bile duct, and fed a stock diet.
contained Vitamin K.

The stock diet

A decrease in prothrombin content

was noted, and soon, the re-establishment of the flow
of bile into the intestinal tract and an increase of
prothrombin was noted in the plasma.

Only when massive

doses of VitAmin K, without the bile salts or bile
itself, were fed, did the
levels.

~rothrombin

rise to normal

They concluded, therefore, "that ( l} bile

fistula rats show loss in blood coagulability and a decrease in the prothrombin level; (2} this condition can
be relieved by administration of Vitamin K concentrate".
(f

Z.

)
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Two months later, Warner and associA.tes (

'?~

)

renorted the first successful treatment of human
patients.

They say in their article, "We have followed

the prothrombin level in human cases, in which bile
feeding was supplemented with a fat soluable extract of
alfalfa meal.

The residue of a petroleum ether extract

of 200 to 400 gm. alfalfa meal was emulsified in human
bile, or, in some cases, in 27b sodium taurocholate
solution, and fed daily.

In a number of patients given

this alfalfa-bile mixture, even with persistance of
Jaundice, the rise in nrothrombin was very rapid.
bleeding existed, it soon ceased.

If

In three cases of

Obstructive Jaundice, the prothrombin level before
therany was 43, 20, and 37%.
salts was given for 6,

s,

.Alfalfa with bile or bile

and 6 days, resnectively.

At the end of the period, the prothrombin values had
risen to 86, 107, and 102%.

The rise in these cases

is considerably faster than with simple bile feeding."
( 7.3

)

Shortly after Warner and associates published
their article, Butt, Snell and Osterberg of the Mayo
Clinic, renorted their findings regarding the usage of
Vitamin Kand bile salts in the treatment of low nrothrombin content of patients suffering from Obstructive
Jaundice.

(?J

Their renort confirmed the findings

-
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of WA.rner, et al.

Eighteen pA.tients with Obstructive

Jaundice were used in their clinical trial of Vitamin
K.

They found that Vitamin K is not effective unless

given with bile salts.

Bile given 11lone, will effect

a decrease in the clotting time, but it is a Rrndunl
and relatively ;:;low decline, whereas, bile sA.l ts plus

Vitamin K, effect a rauid decrease in the clotting
"'· I, .... ,.. ... 1-.v
time. ;::>~. 'n ,#- t:-" "' .......c;;;::,
·h '&

,~11

11).1)

' ""'
,'

'A

AA 11 L. ~ J>
r

/

I

il .,,

'..J u

13 i

i

VI 11'"4 lu .. 1... ,. I<

2.o

•

L.£:

J,

\.

)

,

~

~

I
r

'

J

::~·

,j)

"

'-...

~v

·-

+>
.c

v

1i>
.,

JJ 11l

~

r--..:...

II

f

Pt-.'"' OCA.Y.5
01~,-... ;.,.

I'

Ii.

r. I o,, , • n

'-'->

c: i.

\

go

I~

JO

0

.$.. ,.

L

'°o

~
0 ,.
J.

a..-+•

r.l i

c

r-f

:~•-

'v

c.

10

~ r-

,

·-~ --~

.

\

:s

i-A

c:

-

--

- 41 -

A,· 1>. t

The clinical findings and observations of
Stev.rart (

~f

) , 01 son ( 9f ) , Rhoades ( 5 9 ) , Johnston

( "/{, ) , Sceil-on, et al, (

"~

) , Dam and GlQvind (3 Y ) ,

and others, hnve confirmed the reports of Warner, et al,
and Butt, et al, which showed thf.lt the bleeding tendency
in biliary fistula rmd obstructive jaundice was due to
a lack of Vitamin K absorption in the absence of bile
from the intestinal tract.
b in content and

R

This led to a low prothrom-

subsequent increase in the clotting

time of the blood.
Greaves ( 3 'I ) added conclusive proof to these
clinical findings with his experimental findings unon
rats.

He showed that in the rats, Vitamin K is carried

ncross the intestinal trAct by means of bile salts.

In

the absence of Vitamin Kor bile salts in the rat, a
lowered prothrombin time occurs, with an increase in the
clotting time.
following:

Hugh R. Butt, et al, ( .25

)

state the

"Even current figures indicate that cholemic

bleeding has accounted for about fifty percent of the
mortality accompanying surgical intervention on patients
having jaundice, and that cholemic bleeding, of itself,
imposes a surgical risk of annroximately five percent.n
The understanding of cholemic bleeding that
these investigators and others have given the medical
profession should prove to be "a big stick" in striking

-
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down the mortality and surgical risk on patients so
afflicted.

In disclosing the causitive factor, they

disclose the treatment, for from their work, we see
that the cause is mainly due to a deficiency of
Vitamin K, a deficiency caused by lack of absorption
through the intestinal tract in the absence of bile
salts.

Thus, a viscious cycle can be broken by addi-

tion of bile and an adequate amount of Vitamin K.
The writer, in this paper, has endeavored to
set out in chronological order, the research and
discoveries that have lead to the present Jmowledge
of Vitamin K's role in jaundice, due to biliary
fistula and obstruction.
In summarizing, we find the following facts:

1.

Cholemic bleeding has been known for centuries.

2.

In obstructive jalllldice and biliary fistula 1
there is an absence of bile from the intestlnal
trA.ct.

3.

Bile salts are necessary for the absorption of
Vitamin K across the intestinal tract.

4.

Vitamin K in large dosages will restore the
prothrombin content to within normal levels.

5.

Bile salts taken with Vitli'.llin K prove to be more
efficacious as a method for restoring the prothrombin content to normal.
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THERAPY:

BILI.ARY FISTULA

.A.ND OBSTHUCTIVE JAUNDICE.

Cantarow has covered the treatment of biliAry
fistula and obstructive jaundice more thoroughly than
other investigators, and we quote from him:
"Vi tr-imin K therapy at the moment is in a transition stage, owing to the recent demonstration of the
chemical nature of the vitamin and the availability of
synthetic preparations which vdll undoubtedly replace
extracts which have been employed heretofore.

Prepara-

tions made from alfalfa and other grains (wheat and oats}
and fish meal have provided the most potent sources until
recently.

'Ihe commercial preparations in most common use

are IG.otogen (.Abbott} and Cerophyl (Cerophyl Laboratories).
The latter is available in tablet and powder form and the
former in soft gelatin capsules (1000 Almquist and Stokstad units; 37,500 Dam units} and in 50 cc. vials, each
cubic centimeter of which contains 1250 Almquist and
Stokstad units.

The Dam unit is defined as the amount

of antihemorrhagic material contained in 2 mg. of dried
spinach.

These meAsures of unit value are obviously of

limited usefulness and will undoubtedly be discarded now

that pure nrenarations of the vitamin are available.
It has been suggested recently that a unit of Vitamin K
activity should be regarded as equivalent to the
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antihemorrhagic effect oI' 1 microgram of nure 2 methyl
-1, 4-naphthoquinone.
"In the treatment and prevention of the hemorrhagic tendency of patients with obstructive jaundice
and bile fistula, before and after operation, Cerophyl
has been given effectively in doses of 5-25 Gm. daily.
Klotogen is usually given in the dosage of one capsule
three times daily or, in severe cases, 8 cc. of the
solution in oil may be administered daily by duodenal
tube.

In such cases bile salts should be administered

in conjunction with the vitamin.
concentrates may be given.

'v\fuole bile or bile

Bile salts are perhaps to

be preferred, in doses of 1-2 Gm. of sodium taurocholate and glycocholate or, preferably, deoxycholic acid,
in the dosage of 3 grains {0.2 Gm.) three times daily.
Synthetic, crystalline Vitamin Kor one of the several
similar naphthoquinones which have been shO"wn. to nossess
Vitamin K activity are now being used.

These prepara-

tions seem to be effective in doses of 1-2 mg. daily,
by mouth.

Bile salts should be given simul ttmeously,

as stated above.

They have also been found to be effect-

ive when given parenterally.
"In the great majority of cases of obstructive

jaundice and bile fistula, the plasma prothrombin increRses nromptly after the institution of this form of
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therapy and usually returns to normal in a few daYs.
A

similar effect may frequently be produced by the

oral administration of whole bile, bile concentrates
or bile salts, without Vitamin K, the latter being
present in the food and in the intestine but inadequately absorbed because of the absence of bile
S.9.1 ts.

HoV1rever, the increase in -prothrombin under

such circumstances is usually much more gradual than
if Vitamin K is given in excess simultaneously.

As

stated nreviously, occasional failure of Vitamin K
therany may be due to the presence of extensive
hepatocellular damage.
11

According to l<,uick, if the prothrombin con-

tent of the blood is below 15 per cent of normal,
transfusion should be resorted to.

The effects are

transitory and this procedure should be used only as
an emergency measure to supplement Vitamin K and bilesalt therauy.

The observations of Lord, .Andrus and

Moore indicate th3t the changes in plasma prothrombin
of the recipient of a transfusion are dependent on the
prothrombin content of the blood of the donor, and may
be calculated on the basis of addition.

Stewart found

an increase of only 6 per cent in one case after transfusion of 600 cc. of blood.
should not be used

b~cause

Blood from "blood banks"
its prothrombin content is
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apt to be low.

According to Rhoads and Panzer,

blood that has been ureserved for a. week: or more is
Dractically useless for this nurpose and thA.t kept
for 3 days is of only slight value.
"Since the nlasma prothrombin may fall quickly,
esuecially after operation, determinations of this
factor must be made frequently during the pre- and postoperative neriods, even though no deficiency is found,
and adequate Vitamin Kand bile-salt therany rm.ist be
provided before and after ODerA.tion unon :OA.tients with
obstructive jaundice and bile fistula."

(a.1)

The above finding agrees with the majority of
investigritors in this field.
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SUMMARY

1.

A new vitamin has been discovered and

named nvi tamin K0 by Hendrik Dam.
2.

Recently, another form of the vitamin

has been isolated, nRmely, Vitamin K2.

The struc-

tural and dmperical formula has been found for
Vitamin Kl and Vitamin K2.

The synthesis of Vi ta-

min K like substances has been performed in the
laboratory.
3.

The vitamin is found in varying amounts

in plants, fish and bacteria.
4.

The vitarain contributes to the formation

of prothrombin in the body, without which aid, the
tendency to hemorrhage appears.
5.

'l'he method for estimAting the Vitamin K

utilization in the body is based upon the prothrombin content of the plasma.

A l°'v prothrombin content

signifies a low intake of Vitamin K, or poor utilization by the body.
6.

Bile salts convey the vitamin across the

intestinal tract.

A deficiency of bile salts results

in decreased absorption of Vitamin K by the intest-

inal mucosa and a subsequent increase in the clotting
time.

In obstructive jaundice and biliary fistula,

bleeding mal{es operating a poor risk.
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7.

'lherapy is designed to raise the pro-

thrombin time and decrease the clotting time.

Bile

salts with Vitamin Kare given preoperatively and
postoperatively.

'lhe result of therany is gauged

by prothrombin estimation.

- 49 -

BIBLIOGRAPHY
1.

Almquist, H. J. md Stokstad, E. L. R.
"Af3say Procedure For Vitamin K (.Antihemorrhagic Vitamin)" Journ. Nutr.
14:235-240 (Sept.) 193?.

2.

Almquist, H. J. "Sources g;i d Nature of
The Chick Gizzard Factor" Journ. Nutr.
14:241-245 (Sept.} 193?.

3.

Almquist, H. J. and Stokstad, E. L. R.
"Factors Influencing The Incidence of
Dietary Hemorrhagic Diseases In Chicks"
Journ. Nutr. 12:329-335 (Sept.) 1936.

4.

Almquist, H. J. and Klose, A. A. "A
Derivative of Vitamin K" Journ. Biol.
Chem. 130:791-793 (Oct.} 1939.

5.

Almquist, H. J. and Klose, A· A·
This Journal 61:1611-1939, quoted by
.Ansbacher, s. and Fernholz, E., .Amer.
Journ. Chem. Soc. 61:1924-1925 (July}
1939.

6.

Almquist, H. J. "]further Studies on The
.Antihemorrhagic Vitamin" Journ. Biol.
Chem. 120:635-640 (Se~t.} 1937.

7.

Almquist, H. J. "Purification of The
.Antihemorrhagic Vitamin" Journ. Biol.
Chem. 114:241-245 (May) 1936.

8.

Almquist, H. J. and Klose, A· A· "The
.Antihemorrhagic Activity of Certain
Naphthoquinones" Journ. .Amer. Chem. Soc.
61:1923-1924 (July) 1939.

9.

Almquist, H. J., Pentler, C. F., Meech! E.,
"Synthesis of the .Antihemorrhagic Vitamin
by Bacteria" Proc. Soc. Exper. Biol. Med.
38:336-338, 1938.

10.

Almquist, H. J. "Chemical and Physical
studies on the Antihemorrhagic Vitamin"
Journ. Biol. Chem. 11?:51?-523 (Feb.) 1937.

- 50 -

11.

.Almquist, H. J. and Klose, A· A. ".Antihemorrhagic Activity of 2-Methyl-l, 4Naphthoquinone" Journ. Biol. Chem. 130:
?87-789 (Oct.) 1939.

12.

Almquist, H. J. and Stokstad, E. L. R.
"Hemorrhagic Chick Disease of Dietary
Origin" Journ. Biol. Chem. 111:105-113
(Sept.) 1935.

13.

.Anderson, R. J. and Newman, M. s. '"Ihe
Chemistry of The Lipids of Tubercle Bacilli
--The Constitution of Phthiocol, The Pigment Isolated From the Human 'fubercle
Bacillus" Journ. Biol. Chem. 103:197-201,
1933.

14.

.Ansbacher, s. and Fernholz, E. "Simple
compounds With Vitamin K Activity" Journ •
.Amer. Chem. Soc. 51:1924-1925, 1939.

15.

.Ansbacher, s. "Vitamin K" Journ. Biol.
Ch~m.
{Proc. of Meeting) 132:
(March)

xiI - x1if
16.

.Ansbacher, s. "Vitamin K" Journ. Biol.
Proc. Proc. Am.er. Biol. Chem. 133: !!! !V, 1940 (March}

17.

Binkley, s. B., Thayer, s. A., Daisy, E. A·,
MacCorquodale, D. w., "The Isolatim of
Vitamin K'' Journ. Biol. Chem. 130:219-234
(Sept.) 1939.

18.

Binkley, s. B., Thayer, s. A-, Daisy, E. A·,
MacCorquodale, D. w., "On The Constitution
of Vitamin K" J • .Am. c. Soc. 51:1928-1929
(July) 1939.

19.

Binkley, s. B., Thayer, s. A., Daisy, E. A•,
MacCorquodale, J.:l w., "Derivatives of Vitamin
IQ. and K2"
.Amer. Joum. Chem. Sog. 51:16121613 (June) 1939.

20.

Binkley, S. B., Thayer, S. A., Daisy, E. A.,
MacCorquodale, D. w., "'Ille Isolatim of
Vitamin IQ. and K2" Journ • .Amer. Chem. Soc.
61:1295 (May) 1939.

- 51 -

21.

Binkley, s. B., Thayer, s. A., Daisy, E. A.,
MacGorquodale, D. W. "Inactivation of
Vitamin K by Li@'_,ht 11 Proc. Soc. Ex:per. Biol.
and Med. 40 :482-483 (March) 1939.

22.

Binkley, s. B., Thayer, s. A., Daisy, E. A.,
MacCorquodale, D. w. "Structure of Vitamin
K2" Proc. Amer. Journ. Biol. Chem. 133:

x!t-xtf:t.

23.

Brinkhous, K. M., Smith, H. P. and Warner,
E. D. "Prothrombin Deficiency and Bleeding
Tendency In Obstructive Jaundice and In
Biliary Fistula. Effects of Feeding Bile
and .Alfalfa {Vitamin K)" Amer. Journ. Med.
Sci. 196:50-57 {July) 1938.

24.

Butt, H. R., Snell, A· M. nThe Use of
Vi tam.in K and Bile In Treatment of the
Hemorrhagic Diathesis In Cases of Jaundice"
Proc. Staff. Meet. Mayo Clinic 13:74-79
(Feb.) 1938.

25.

Butt, Hugh, .Snell, A., Osterberg, A·
'"lhe
Preoperative and Postonerative Administration of Vitamin K" J. A.M. A· 113: 383-389
(July) 1939.

26.

Butt, H. R., Snell, A· M., and Osterberg,
A· E. "Further Observations On The Use of
Vitamin K In The Prevention and Control of
The Hemorrhagic Diathesis in Cases of
Jaundice" Proc. Staff. Meet. Mayo Clinic
13:753 (Nov.) 1938.

27.

Cantrow, A., "Review of Recent Progress Vitamins" The New International Clinics
1:221-307 (March) 1940.

28.

Dam, H., and Tage-Hansen, E. "Studies on
The Mode of Action of Vitamin K" Biochem.
Journ. 30:1075-1079, 1936.

29.

Dam, H., and Schonheyder, F. "The Occurance
and Ghemical Nature of Vitamin K" Biochem.
Journ. 30:897-901, 1936.

30.

Dam, Hendrik, rrrlhe .Antihemorrhngic Vitamin
of the Chick" Journ. Biochem. 29:1273-1284
(April) 1935.

- 52 -

31.

Dam, Hendrik, ·1 cholesterol Synthesis In
The Animal Body" Biochem. 6tschr. 220:
158-1930. Ibid. McCoy, C. M.

32.

Dam, H., and Lewis, L., '"Ihe Chemical
Concentration of Vi ta.min K" Biochem.
Journ. 31:17, 19, 1936.

33.

Dam, Hendrik, 11 Cholesterol Metabolism In
Chickens A.nd Chicken Eggs" Biochem.
Ztschr. 215:475, 1929. Ibid. McCoy, C.M.

34.

Dam, Hendrik,
Lane et

l ogyt'

35.

"Vitamin K: In Human Pathol: 720-721 (March) 1938.

Dam, Hendrik and Glavind, JohA.nnes "Vitamin

K In the PlAnt"

Journ. Biochem.

32:485-

493, 1938.
36.

:Ehunet, A· D., Kamm, O., Sharp, E. A.
"Vitamin K Activity of 4-.Amino-2-Methyl-1
-Naphthol and 4-.Amino-3-Methyl-l-Naphthol"
Journ. Biol. Chem. 133:285-286 (March)
1940.

3?.

Fieser, L. F., Bowen, D. M., Cambell, w. P.,
Fry, E. M., Gates, M. D., Jr. "Synthesis
on .An tihemorrhage Compotmdsn Journ. .Amer.
Chem. Soc. 61:1926-1927 (July) 1939.

38.

Fieser, L. F., Bowen, D. M., Cambell, w. P.,
Fieser, M., Fry, E. M., Jones, R. N.
"Quinones Having Vitamin K Ac ti vi ty" Journ •
.Amer. Chem. Soc. 61:1925-1926 (July) 1939.

39.

Greaves, J. D. "The Nature of' the Factor
Which Is Concerned In Loss of Blood Coagulabili ty of Bile Fistula and Jaundiced Rats"
.Am. Journ. Physiol. 125:423-428 (Mar.) 1939.

40.

Greaves, J. D. "Studies on the Vitamin K
Requirements of the Rat" Amer. Journ. Physiol.
125:429-435 (March) 1939.

41.

Greaves, J. D. A.nd Schmidt, c. L. A. "The
Role Played By Bile In Absorption of Vitamin
D In the Rat" Journ. Biol. Chem. 102: 101111 (Sept.) 1933.

- 53 -

42.

Greaves, J. D. A.nd Schmidt, c. L. A. ''Nature of The Factor Concerned In Loss of
Blood Coagulabili ty of Bile Fistula Rats"
Proc. Soc. Ex:per. Biol. and Med. 37: 4345' 1937.

43.

Hawkins, W. B. and Brinkhous, K. M.
"Prothrombin Deficiency the Cause of Bleeding In Bile Fistula Dogs" Journ. Exper.
Med. 63:795-801 (June)
1936.

44.

Howell, w. H.
Ibid. Q,uick.

45.

Illingworth, c. F. "Hemorrhage In Jaundice"
Lancet 1:1031-1035 (May) 1939.

46.

Johnston, C. G. "Preoperative and Postoperative Treatment in Cases of Obstructive
Jaundice" surgery 3:875-883 (June) 1938.

47.

McCoy, C. M. "Other Factors: Less Well
Known Vittfllins" J.A.M.A. 110:1441-1446
(April) 1938.

48.

Olson, P. F. "Prothrombin Test and Vi tam.in
K For Bleeding" J.A.M.A. 112:2094-2094
(April) 1939.

49.

.Olson, P. F. "The Prothrombin Test and The
Vitamin K Treatment for the Bleeding Tendency
in the Jaundiced Patient" Journ. Iowa Med.
Soc. 29:103-104 (March) 1939.

50.

Opitz, H. and Frei, M.
Jahrl. F. Kindert.
94:116-1921
Ibid. Q,uick.

51.

Osterberg, A· E. "Vitamin K: Its Distribution and Chemical Properties. Methods of
Pronerties and Assay" Proc. Staff. Meet.
Mayo Clinic 13:72-73 (Feb.) 1938.

52.

Peirce, Dann, Flemintine. "Vitamin K Assay"
.Amer. Journ. Physiol. Proc. 123:48-49
(July) 1938.

53.

(),uick, J. A., Brovm., M.s. !. Bancroft, F. "A
Study of the CoagulAtion LJefect In Hemophilia
and In Jaundice" .Am. Journ. Med. Sci. 190:
501-511, 1935.

Arch. Int. Med.

- 54 -

13:76, 1914.

54.

q,uick, J. Armand. "The Nature of The Bleeding In J riundic e 11 J. A.M. A· 110: 1658-1662
(Mriy) 1938.

55.

'J:uick, J. .Armand.
109:66-66 (July)

56.

Quick, J. Armand. 11 The Nature of The Bleeding In Jaundice" J .A.M.A. 110:1658-1662
(May) 1938.

5?.

Quick, J. Armand. "On Various Pronerties. of
Thromboplastin (Aqueous Tissue Ex:tracts)"
.Amer. Journ. Physiol. 114:282 (Jan.) 1936.

58.

Rabe, F. and Salmon, E. Deutch .u-ch. Klin.
Med. 132:240 1920. Ibid. lctUick.

59.

Rhoades, J. E. "The Relation of Vi taro.in K
to the Hemorrhagic Tendency in Obstructive
Jaundice with a Report on Cerophyl as a
Source of Vitamin K" Surgery 5: ?94 {May)
1939.

60.

Rhoades, J. E. Rnd Panzer, L. M. "The
RelAtion of Vi tF1min K to the Hemorrhagic
Tendency In Obstructive Jaundice with a
Renort on Ceronhyl as a Source of Vitamin
K" J.A.M.A. 112:309-311 {Jan.) 1939.

61.

Rhoderick, Lee M. . "The Pathology of Sweet
Clover Disease In Cattle" Journ • .Amer.
Vet. Assoc. ?4:314-335 (Feb.} 1929.

62.

Scanlon, G. H., Brinkhous, K. M., Warner,
E. D., Smith, H. P. and Flynn, J. E.
"Plasma Prothrombin and the Bleeding Tendency, with Special Reference to Jaundice
Patients and Vitamin K Therapy" J .A.M.A.
112:1898-1901 {May) 1939.

63.

Scott, F. H., and Chamberlain, c. Proc.
Soc. Ex:per. Biol. and Med. 31 :1054.
1933-1934. Ibid. Quick.

64.

Seifert, E. Beitr. Klin. Chir. 136:496
(1926) Ibid. Greaves. J.B.c. 102:101-111.

"Vi to.min Ku
193?.

- 55 -

J. A.M. A.

65.

Smith, H. P., Warneri E. D. and Brinkhous,
K. M. "Prothrombin ueficiency and the
Bleeding Tendency In Liver Inury (Chloroform Intoxication}" Journ. Ex:per. Med.
66:801-811 (Dec.) 193?.

66.

Smith, H.P., Hoffman, G. R., Owen, C. A.,
Zifferen, s. E. uclinical nnd Ex:nerimental
Studies On Vitamin K" J.A.M.A. 113:380383 (July) 1939.

6?.

Snell, A M. "Vitamin K, Its Properties,
Distribution R!ld Clinical Importance"
J.A.M·A· 112:1457-1459 (~pril) 1939.

68.

Stewart, J. D. "Prothrombin Deficiency alffi
The Effects of Vite.min Kin Obstructive
Jaundice and Biliary Fi stulatt .Ann. Surg.
109:588 (April) 1939.

69.

Thayer, S. A•, MacCorquodale, D. W., McKee,
R. w. and Daisy, E. A. "The Isolation of a
Crystalline Comnound with Vi tam.in K Activity"
Science 88:243, 1938.

?O.

Warner, E. D., Brinkhaus, K. M., and &'mith,
H. P. "Quan ti tr.itive Study on Blood Clotting:
Prothrombin Fluctuations Under Ex:nerimental
Conditions"
Journ. Amer. Physiol. 114:
66?-6?5 {Feb.} 1936.

?l.

Warner, E. D., Brinkhous, K. M., and 8mith,
H. P. "Prothrombin Deficiency and the Bleeding Tendency In Liver Injury (Chloroform
Intoxication}" Journ. Ex:per. Med. 66:801811 (Dec.) 193?.
·

?2.

Warner, E. D. "Plasma Prothrombin: Effect
of Partial Hepatectomy" Journ • .JTucper. Med.
68:831-835 (Dec.) 1938.

?3.

Warner, E. D., Brinkhous, K. M., and &In.1th,
H. P. "Bleeding Tendency of Obstructive
Jaundice: Prothrombin Deficiency and Dietary Factors" Proc. Soc. Ex:per. Biol. and
Med. 37:628-630 (Jan) 1938.

- 56 -

74.

Wedelius, D. G. W. "De Hoemorrhagica Universali, Ex:ictero Nigro Lethali. Mi scellananae Guriosa Medico Physica i\Cademiae
Caesarear Leopoldino, Carolina Natural
Curiosorum, Lipsial. n 1607-1705. 2: 318319, 1683, Ibid. Butt, et al.

75.

6ifferen, s, E., Owen, c. A., Hoffman, G. R.,
Smith, H. P. "Control of Vitamin K Therapy
--Compensatory Mechanisms at Low Prothrombin
Levels" Proc, Soc. Ex:per. Biol. and Med.
40:595-597 (April) 1939.

76.

Stokstad, E. L. R. and Manning, P. D. U.
"Evidence of a New Growth Factor Required
by Chicks" Journ. Biol. Chem. 125:687-696
(Oct.) 1938.

77.

Klose, A· A., Almquist, H. J. 1 and Meechi,
E. J. "Pronerties of' The .Ant1hemorrhRgic
Vitamin"
Chem. 125:681-686 (Oct.) 1938.

- 57 -

